/PRNewswire/ We are pleased to announce that Actym Therapeutics President and CEO, Dr. Christopher Thanos, has been named one of the "Top 25 Biotech CEOs.
/PRNewswire/ Actym Therapeutics, a privately-held biotechnology company focused on the discovery and development of novel immuno-oncology therapies to treat.